Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: A cohort study

British Journal of Cancer

Volumn 107, Issue 9, 2012, Pages 1602-1607

  Walker, A J ^a   Grainge, M J ^a   Card, T R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

aspirin; colorectal cancer; GPRD; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HAZARD RATIO; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SMOKING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84867897314     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.427     Document Type: Article

References (20)

1. Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJM, van Herk-Sukel MPP, Lemmens V, van den Broek CBM, Coebergh JW, Herings RMC, van de Velde CJH, Fodde R, Liefers GJ (2012) Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 106(9): 1564-1570
2. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302(6): 649-658
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5): 373-383
4. Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM (2010) Prediagnostic non-steroidal antiinflammatory drug use and survival after diagnosis of colorectal cancer. Gut 60(4): 491-498
5. Colorectal Cancer Collaborative Group (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Bmj 321(7260): 531-535
6. Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M, Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5): 501-507
7. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59(12): 1670-1679
8. Dregan A, Moller H, Murray-Thomas T, Gulliford MC (2012) Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol 36(5): 425-429
9. Dubé C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146(5): 365-375
10. Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G, Elwood PC, Gallagher AM, Duthie GG, Mur LAJ, Morgan G (2009) Aspirin, salicylates, and cancer. Lancet 373(9671): 1301-1309
11. Fombonne E, Heavey L, Smeeth L, Rodrigues LC, Cook C, Smith PG, Meng L, Hall AJ, Fombonne E, Heavey L, Smeeth L, Rodrigues LC, Cook C, Smith PG, Meng L, Hall AJ (2004) Validation of the diagnosis of autism in general practitioner records. BMC Public Health 4: 5
12. Half E, Arber N, Half E, Arber N (2009) Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 10(2): 211-219
13. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69(1): 4-14
14. Iwama T, Iwama T (2009) NSAIDs and colorectal cancer prevention. J Gastroenterol 44(Suppl 19): 72-76
15. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Bmj 302(6779): 766-768
16. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H, Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H (2003) Validity of the general practice research database. Pharmacotherapy 23(5): 686-689
17. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW (2010) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759): 31-41
18. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz J-F, Thompson P, Vieitez JM, Weitzel C, Harper P (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19(21): 4097-4106
19. Welch S, Spithoff K, Rumble RB, Maroun J (2010) Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol 21(6): 1152-1162
20. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H (2009) Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. Cancer 115(24): 5662-5671